We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Updates Assessment, Acceptance Criteria in Final ITP Guidance
EMA Updates Assessment, Acceptance Criteria in Final ITP Guidance
The European Medicines Agency has backed off of several controversial limitations it was considering imposing on sponsors of trials for treatments for chronic primary immune thrombocytopenia.